Interpace Biosciences, Inc. Financial Ratios — IDXG Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	-164.48	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-10.02	-26.61	-6.19	-17.38	-12.37	-15.22	-25.62	-29.99	-64.69	-54.41	-35.53	-80.72	13.43	48.03	101.07
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-20.91	-38.25	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-42.69	- -
Gross Margin (%)	20.64	21.17	16.04	13.98	26.74	49.25	53.71	53.43	34.4	33.1	56.78	57.26	62.58	63.77	62.31
EBITDA Margin (%)	0.78	0.81	-0.01	-905.63	-273.88	-79.91	-51.61	-33.39	-80.19	-57.03	-1.18	-1.06	13.9	18.87	12.67
Operating Margin (%)	-1.15	-0.8	-0.98	-1,067.84	-327.21	-114.17	-74.83	-50.74	-98.87	-74.01	-17.4	-12.06	9.9	17.28	10.55
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	95.18	60.16	49.09
Pretax Margin (%)	-3	-19.91	-1.02	-1,254.82	-468.68	-65.51	-82.61	-58.01	-110.16	-80.71	-23.38	-18.33	5.7	14.81	9.74
Profit Margin (%)	-7.57	-20.12	-3.12	-1,090.43	-120.4	-63.68	-76.84	-58.02	-110.4	-81.64	-45.12	-68.97	4.88	14.28	63.46
Net Income to Common Margin (%)	-7.57	-20.12	-3.12	-1,090.43	-120.4	-63.68	-76.84	-58.02	-112.18	-81.64	-45.12	-68.97	4.88	13.29	63.46
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.75	0.06	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.58	- -	- -	- -	- -	-7.16	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	-164.48	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	27	8	8	- -	- -	7	5	11	16	11	6	1
ST Debt	- -	- -	- -	- -	1	- -	- -	- -	2	1	1	3	5	5	- -
LT Debt	- -	- -	- -	27	7	8	- -	- -	6	4	10	13	6	1	1
Total Debt/EBITDA	- -	- -	- -	-2.03	-0.33	-0.76	- -	- -	-0.37	-0.26	-27.5	-47.61	2.01	0.66	0.24
Net Debt/EBITDA	-52.18	-51.5	3,803.25	-0.3	- -	-0.7	1.85	0.83	-0.03	0.15	-17.36	-26.14	1.05	0.32	-0.51
Total Debt/EBIT	- -	- -	- -	-1.73	-0.27	-0.53	- -	- -	-0.3	-0.2	-1.86	-4.19	2.82	0.72	0.29
Net Debt/EBIT	35.49	52.31	31.76	-0.26	- -	-0.49	1.28	0.55	-0.03	0.12	-1.17	-2.3	1.47	0.35	-0.61
EBITDA to Interest Expense	- -	- -	- -	-22.17	-6.97	-4.88	-18.95	-22.08	-44.14	-33.65	-0.38	-0.34	5.52	13.44	29.2
EBITDA-CapEx/Interest Expense	- -	- -	- -	-41.03	-7.07	-4.88	-19.02	-23.44	-44.44	-36.52	-0.72	-0.65	5.05	12.11	27.08
EBIT to Interest Expense	- -	- -	- -	-26.15	-8.33	-6.97	-27.47	-33.57	-54.42	-43.67	-5.54	-3.81	3.93	12.3	24.31
Interest Expense	- -	- -	- -	1	4	2	- -	- -	- -	1	1	1	1	1	- -
Common Equity/Total Assets	- -	- -	- -	- -	- -	- -	- -	49.62	-8.69	-101.87	-121.1	- -	-423.44	- -	- -
Long-Term Debt/Equity (%)	- -	- -	- -	134.95	55.48	121.08	- -	- -	25.77	- -	- -	- -	- -	- -	3.36
Long-Term Debt/Capital (%)	- -	- -	- -	100	86.14	100	- -	- -	19.42	74.62	92.89	80.87	-12.89	20.2	63.57
Long-Term Debt/Total Assets (%)	- -	- -	- -	23.43	10.68	18.93	- -	- -	10.85	7.75	25.92	81.44	43.57	8	2.22
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	32.71	- -	- -	- -	-20.15	- -	- -
Total Debt/Capital (%)	- -	- -	- -	100	100	100	- -	- -	24.65	100	100	100	-25.24	100	100
Total Debt/Total Assets (%)	- -	- -	- -	23.43	12.4	18.93	- -	- -	13.77	10.39	27.91	100.7	85.33	39.59	3.5
Net Debt to Equity	- -	- -	- -	- -	- -	- -	- -	-39.29	3.13	- -	- -	- -	-10.52	- -	- -
Net Debt/Capital (%)	100	100	100	100	100	100	100	-64.7	2.57	-140.57	84.08	78.46	-12.22	64.37	189.49
EBITDA	1	1	- -	-13	-26	-10	-8	-7	-19	-18	- -	- -	6	9	5
EBITDA-CapEx	1	- -	-2	-25	-26	-10	-8	-8	-20	-20	-1	-1	5	8	5
Operating Income (Loss)	-2	-1	-1	-16	-31	-15	-12	-11	-24	-24	-6	-4	4	8	4

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.4	1.45	1.46	0.69	0.36	0.04	1.88	0.7	0.13	0.15	0.17	0.34	0.31	0.14	0.49
Current Ratio	1.74	1.97	2	1.34	0.82	0.26	2.45	2.04	0.95	0.77	0.78	0.85	0.91	1.11	1.94
Quick Ratio	1.66	1.8	1.77	0.86	0.52	0.19	2.3	1.79	0.73	0.59	0.47	0.69	0.75	0.94	1.6
CFO/Avg Current Liab	0.04	-0.25	-0.1	-0.5	-0.7	-0.38	-1.25	-1.03	-1.46	-0.79	-0.51	-0.51	0.29	0.42	0.74
Common Equity/Total Assets	- -	- -	- -	- -	- -	- -	- -	49.62	-8.69	-101.87	-121.1	- -	-423.44	- -	- -
Long-Term Debt/Equity (%)	- -	- -	- -	134.95	55.48	121.08	- -	- -	25.77	- -	- -	- -	- -	- -	3.36
Long-Term Debt/Capital (%)	- -	- -	- -	100	86.14	100	- -	- -	19.42	74.62	92.89	80.87	-12.89	20.2	63.57
Long-Term Debt/Total Assets (%)	- -	- -	- -	23.43	10.68	18.93	- -	- -	10.85	7.75	25.92	81.44	43.57	8	2.22
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	32.71	- -	- -	- -	-20.15	- -	- -
Total Debt/Capital (%)	- -	- -	- -	100	100	100	- -	- -	24.65	100	100	100	-25.24	100	100
Total Debt/Total Assets (%)	- -	- -	- -	23.43	12.4	18.93	- -	- -	13.77	10.39	27.91	100.7	85.33	39.59	3.5
CFO/Total Liabilities	3.69	-24.02	-9.6	-17.1	-36.29	-21.58	-111.17	-55.31	-63.51	-18.7	-10.78	-9.73	5.52	27.31	50.81
CFO/CapEx	5.79	-9.25	-1.93	-1.44	-56.21	- -	-526.31	-19.32	-144.71	-8.88	-24.63	-23.89	8.06	5.3	16.38
Altman's Z-Score	6.62	8.69	6.88	-2.47	-10	-39.41	-3.25	-7.79	-9.61	-12.95	-7.32	-21.79	-21.68	-15.1	-5.58

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	15.2	12.49	23.28	0.51	2.84	5.22	5.63	3.39	2.44	3.53	5.22	6.56	7.92	6.89	5.46
Days Sales Outstanding	24.01	29.22	15.68	710.56	128.52	69.95	64.82	107.69	149.35	103.46	69.99	55.62	46.09	52.98	66.88
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	17.41	11.18	9.95	13.28	12.22	13.95	12.56
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	20.96	32.65	36.68	27.48	29.86	26.17	29.07
Accounts Payable Turnover	33.71	26.58	44.03	0.58	3.71	3.42	5.42	14.06	6.14	4.75	4.45	11.56	11.55	10.61	10.98
Accounts Payable Turnover Days	10.83	13.73	8.29	627.81	98.3	106.79	67.39	25.95	59.43	76.83	82.07	31.59	31.6	34.42	33.25
Cash Conversion Cycle	13.18	15.49	7.39	82.75	30.21	-36.84	-2.57	81.74	110.89	59.27	24.6	51.52	44.35	44.73	62.7
Inventory to Cash Days	24.01	29.22	15.68	710.56	128.52	69.95	64.82	107.69	128.39	70.81	33.31	28.14	16.23	26.81	37.82
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1	1	1
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	473	569	365	137	41	48	142	115	98	64	157	22	23	60	27
- Cash & Cash Equivalents	64	53	46	23	8	1	15	6	2	3	3	5	3	1	3
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	26	47	47	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	27	8	8	- -	- -	7	5	11	16	11	6	1
Enterprise Value	409	516	319	141	41	55	127	109	129	112	211	34	31	64	26
Total Capital	- -	- -	- -	27	8	8	- -	15	29	5	11	16	-44	6	1
Total Debt/Capital (%)	- -	- -	- -	100	100	100	- -	- -	24.65	100	100	100	-25.24	100	100
Total Debt / EV	- -	- -	- -	0.19	0.2	0.14	- -	- -	0.06	0.04	0.05	0.48	0.36	0.09	0.05
EV/Sales	2.6	4.06	2.18	95.94	4.35	4.22	7.97	4.96	5.32	3.46	6.38	1.06	0.78	1.36	0.67
EV/EBITDA	331.59	503.24	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.61	7.22	5.28
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.87	7.88	6.35
EV/Cash Flow to Firm	205.97	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.51	12.05	3.73
EV/Free Cash Flow to Firm	175.62	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.93	10.34	3.55
Diluted Market Cap	464	554	354	133	36	40	80	113	94	63	154	22	24	212	170
Diluted Enterprise Value	399	501	308	137	36	47	65	107	125	112	209	33	31	217	169
EV per Share	2,772.8	3,446.69	2,103.47	920.62	232.39	253.57	45.54	37.89	32.89	27.66	50.36	7.82	7.17	14.5	5.85
TTM Sales	157	127	147	1	9	13	16	22	24	32	33	32	40	47	39
TTM EBITDA	1	1	- -	-13	-26	-10	-8	-7	-19	-18	- -	- -	6	9	5
TTM Operating Income	-2	-1	-1	-16	-31	-15	-12	-11	-24	-24	-6	-4	4	8	4
TTM Cash Flow to Firm	2	-10	-4	-16	-17	-6	-15	-8	-19	-13	-8	-7	5	5	7
TTM Free Cash Flow to Firm	2	-9	-2	-5	-17	-6	-15	-8	-18	-12	-7	-6	5	6	7

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	199.11	-60.41	-208.95	-26.53	-1.85	-5.25	-5.28	-13.69	-4.97	-5.1	-18.46	-2.99	5.53	38.47	27.53
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.87	7.88	6.35
Enterprise Value	409	516	319	141	41	55	127	109	129	112	211	34	31	64	26
Low Price	2,635	2,920	1,910	670	211	35	36	38.15	19.05	12.86	14.9	2.55	3.1	4.1	2.22
EV/Sales	2.6	4.06	2.18	95.94	4.35	4.22	7.97	4.96	5.32	3.46	6.38	1.06	0.78	1.36	0.67
EV/EBITDA	331.59	503.24	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.61	7.22	5.28
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.93	9.49	1.11
Price/Earnings Average	-45.76	-20.61	-86.43	-17.24	-10.38	-3.38	-12.75	-11.96	-5.33	-3.84	-10.56	-3.18	14.12	5.93	0.9
Price/Earnings High	-68.78	-25.37	-132.99	-28.97	-18.68	-21.58	-91.96	-19.73	-7.69	-8.38	-14.54	-8.19	39.1	12.45	2.43
Price/Earnings Low	-31.94	-16.68	-61.58	-6.21	-2.88	-0.76	-4.65	-8.46	-2.63	-1.96	-4.12	-0.49	6.85	2.88	0.4
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	7.43	-21.88	-1.37	-3.37	- -	-0.42	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	10.03	-33.84	-2.2	-3.44	- -	-0.5	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	16.53	-48.83	-4.79	-4.74	- -	-1.39	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	7.09	-16.67	-1.12	-1.34	- -	-0.24	- -	- -
Price/Tangible Book Value	-18.05	-225.41	- -	-2.19	-0.94	-1.32	-4.29	39.47	-3.41	-0.96	-3.22	-25.95	-0.42	- -	- -
Price/Tangible Book Value Average	-21.23	-213.99	- -	-4.54	-3.09	-0.93	-8.3	53.25	-5.27	-1.54	-3.29	-82.35	-0.5	- -	- -
Price/Tangible Book Value High	-31.92	-263.37	- -	-7.64	-5.56	-5.93	-59.91	87.82	-7.61	-3.36	-4.53	-211.84	-1.39	- -	- -
Price/Tangible Book Value Low	-14.82	-173.21	- -	-1.64	-0.86	-0.21	-3.03	37.64	-2.6	-0.79	-1.28	-12.73	-0.24	- -	- -
Price/Sales	2.95	4.37	2.42	90.48	3.82	3.05	5.06	5.14	3.87	1.95	4.66	0.69	0.58	1.26	0.7
Price/Sales Average	3.47	4.15	2.69	187.94	12.5	2.15	9.79	6.94	5.98	3.13	4.76	2.2	0.69	0.79	0.57
Price/Sales High	5.21	5.1	4.14	315.91	22.48	13.74	70.66	11.44	8.63	6.84	6.56	5.65	1.91	1.65	1.54
Price/Sales Low	2.42	3.36	1.92	67.73	3.46	0.49	3.57	4.91	2.95	1.6	1.86	0.34	0.33	0.38	0.25
Price/Cash Flow	233.51	-53.88	-100.79	-8.14	-1.81	-5.25	-5.27	-12.99	-4.94	-4.53	-17.71	-2.87	6.15	12.75	4.67
Price/Cash Flow Average	274.65	-51.15	-112.34	-16.91	-5.94	-3.7	-10.2	-17.52	-7.64	-7.27	-18.09	-9.09	7.28	7.96	3.79
Price/Cash Flow High	412.83	-62.96	-172.87	-28.43	-10.69	-23.63	-73.6	-28.89	-11.02	-15.85	-24.92	-23.39	20.17	16.71	10.24
Price/Cash Flow Low	191.68	-41.4	-80.04	-6.1	-1.65	-0.84	-3.72	-12.38	-3.76	-3.71	-7.07	-1.4	3.53	3.87	1.68
Price/Free Cash Flow Average	234.19	-57.35	-232.91	-55.11	-6.05	-3.7	-10.22	-18.48	-7.69	-8.19	-18.86	-9.49	6.55	24.02	22.37
Price/Free Cash Flow High	352.01	-70.59	-358.39	-92.63	-10.88	-23.63	-73.74	-30.47	-11.1	-17.86	-25.98	-24.41	18.14	50.43	60.43
Price/Free Cash Flow Low	163.44	-46.42	-165.95	-19.86	-1.68	-0.84	-3.73	-13.06	-3.79	-4.18	-7.37	-1.47	3.18	11.68	9.94
EV/Sales Average	3.13	3.84	2.46	196.48	14.27	3.14	16.34	6.79	7.54	4.65	6.48	2.58	0.89	0.89	0.54
EV/Sales High	4.91	4.82	3.96	328.41	25.66	17.02	123.81	11.39	10.31	8.38	8.31	6.08	2.12	1.76	1.51
EV/Sales Low	2.06	3.03	1.67	72.57	3.96	1.14	5.35	4.72	4.36	3.11	3.54	0.7	0.53	0.48	0.22
EV/EBITDA Average	399.32	475.23	-30,084.62	-21.7	-5.21	-3.93	-31.65	-20.35	-9.4	-8.16	-550.32	-243.09	6.38	4.69	4.24
EV/EBITDA High	626.47	596.78	-48,342.94	-36.26	-9.37	-21.3	-239.87	-34.11	-12.86	-14.7	-705.27	-572.95	15.23	9.31	11.92
EV/EBITDA Low	262.93	374.85	-20,342.02	-8.01	-1.45	-1.43	-10.36	-14.15	-5.44	-5.45	-300.26	-65.74	3.81	2.54	1.73
EV/EBIT Average	-271.57	-482.77	-251.23	-18.4	-4.36	-2.75	-21.83	-13.39	-7.62	-6.29	-37.24	-21.4	8.96	5.13	5.1
EV/EBIT High	-426.05	-606.24	-403.7	-30.75	-7.84	-14.91	-165.46	-22.44	-10.43	-11.33	-47.72	-50.43	21.38	10.17	14.32
EV/EBIT Low	-178.81	-380.79	-169.87	-6.8	-1.21	-1	-7.15	-9.31	-4.41	-4.2	-20.32	-5.79	5.35	2.77	2.08
Last Price	3,210	3,800	2,405	895	232.5	220	51	40	25	15.7	37.35	5.2	5.4	13.5	6.15
High Price	5,675	4,440	4,125	3,125	1,370	990	712.5	89	55.79	55	52.55	42.45	17.7	17.7	13.5
Enterprise Value Average	492	487	361	290	135	41	260	149	183	151	215	82	35	42	21
Enterprise Value High	772	612	580	484	242	223	1,968	249	250	272	275	194	85	82	58
Enterprise Value Low	324	384	244	107	37	15	85	103	106	101	117	22	21	22	9

Shares Outstanding	- -	- -	- -	- -	- -	- -	3	3	4	4	4	4	4	4	4
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	2	3	4	4	4	4	4	16	28
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	2	3	4	4	4	4	4	4	4
Revenue per Share	1,089.27	870.07	995.61	9.89	60.93	72.05	10.08	7.78	6.47	8.04	8.01	7.51	9.27	10.7	8.75
EBITDA per Share	8.54	7.03	-0.08	-89.58	-166.87	-57.58	-5.2	-2.6	-5.18	-4.59	-0.09	-0.08	1.29	2.02	1.11
Operating Income per Share	-12.56	-6.92	-9.76	-105.63	-199.37	-82.26	-7.54	-3.95	-6.39	-5.95	-1.39	-0.91	0.92	1.85	0.92
Basic EPS, GAAP	-82.51	-175.02	-31.02	-107.87	-73.36	-45.88	-7.75	-4.51	-7.25	-6.57	-3.61	-5.18	0.45	1.42	5.55
Basic EPS from Cont Ops	-26.16	-174.62	-11.39	-90.37	-200.71	-46.31	-8.08	-4.52	-7.11	-6.5	-1.7	-1.38	0.52	1.58	5.65
Diluted EPS, GAAP	-82.51	-175.02	-31.02	-107.87	-73.36	-45.88	-7.75	-4.51	-7.25	-6.57	-3.61	-5.18	0.45	0.4	0.89
Diluted EPS from Cont Ops	-26.16	-174.62	-11.39	-90.37	-200.71	-46.31	-8.08	-4.52	-7.11	-6.5	-1.7	-1.38	0.52	0.44	0.9
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	13.75	-70.52	-23.86	-109.91	-128.18	-41.89	-9.68	-3.08	-5.06	-3.47	-2.11	-1.82	0.88	1.06	1.32
Free Cash Flow per Basic Share	11.37	-78.15	-36.21	-186.09	-130.46	-41.89	-9.7	-3.24	-5.1	-3.86	-2.19	-1.89	0.77	0.86	1.24
Cash & Equivalents per Share	437.2	353.31	301.53	151.15	47.65	2.77	5.46	2.11	0.59	0.68	0.64	1.12	0.8	0.33	0.57
Book Value per Share	- -	- -	- -	- -	- -	- -	- -	5.38	-1.14	-11.47	-11.09	- -	-12.76	- -	- -
Tangible Book Value per Share	-177.8	-16.86	- -	-409.14	-246.24	-167.07	-11.89	1.01	-7.34	-16.35	-11.6	-0.2	-12.76	- -	- -

Interpace Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)